Press release
Rising Comorbidities Fueling The Growth Of The Market Due To Increasing Aging Population And Obesity Risk: Strengthening the Growth Trajectory of the Digital Therapeutics Sarcopenia Market
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.What Is the Expected CAGR for the Digital Therapeutics Sarcopenia Market Through 2025?
In the past several years, the market size for digital therapeutics sarcopenia has significantly ballooned. A jump from $1.32 billion in 2024 to $1.54 billion in 2025, showing a compound annual growth rate (CAGR) of 16.3%, exhibits this expansion. Factors such as an increase in the elderly demographic, rising instances of muscle loss connected to aging, a heightening awareness about sarcopenia, amplified adoption of telehealth, a mounting demand for home-borne rehabilitation, and government initiatives favoring digital healthcare have all made a significant contribution to the growth observed in the historic period.
What's the Projected Size of the Global Digital Therapeutics Sarcopenia Market by 2029?
Anticipated rapid surge can be seen in the digital therapeutics sarcopenia market in the coming years, with a projection to reach $2.78 billion by 2029, expanding at a compound annual growth rate (CAGR) of 16.0%. The growth is driven by factors including an increasing ageing population, proliferating emphasis on preserving muscle health, the ever-increasing role of AI in digital therapeutics, improved reimbursement policies for DTx, the introduction of personalized exercise regimes, cementing partnerships between technology companies and healthcare providers, and a rising inclination towards remote rehabilitation solutions. Key trends during the projected period involve progression in AI-guided personalized exercise programs, incorporation with wearable health trackers, extending tele-rehabilitation platforms, its inclusion in elderly care, amplified remote patient monitoring abilities, and advancements in digital health solutions.
View the full report here:
https://www.thebusinessresearchcompany.com/report/digital-therapeutics-sarcopenia-global-market-report
Top Growth Drivers in the Digital Therapeutics Sarcopenia Industry: What's Accelerating the Market?
The growth of the digital therapeutics sarcopenia market is likely to be driven by the increasing presence of comorbidities. Comorbidities, the coincidental existence of two or more health issues in a single person, are becoming more prevalent due to an aging population. This is because the chance of developing several chronic diseases tends to rise with age due to deteriorating physiological functionality and long-term health risk exposure. Digital therapeutic solutions for sarcopenia can aid in preventing comorbidities, particularly obesity, by encouraging consistent exercise and muscle fortifying, which boosts metabolism and mitigates fat buildup. The World Obesity Federation, a UK-based membership organization, reported in March 2024 that roughly 79% of adults struggling with overweight and obesity are predicted to reside in low and middle-income countries by 2035. The total count of adults with obesity is expected to surge to 1.53 billion. As a result, the escalating prevalence of comorbidities is fuelling the expansion of the digital therapeutics sarcopenia market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27278&type=smp
What Long-Term Trends Will Define the Future of the Digital Therapeutics Sarcopenia Market?
Leading firms in the sarcopenia digital therapeutics market are prioritizing the development of enhanced solutions such as drug discovery platforms. These platforms aim to foster the creation of more specialized therapies, improve treatment efficacy and hasten the delivery of personalized care for age-associated muscle deterioration. A drug discovery platform accelerates the invention of new drugs effectively and efficiently by employing cutting-edge techniques and tools. For example, in April 2025, ProFuse Technology, a biotech firm based in Israel, introduced a novel drug discovery platform that emphasizes preventing muscle degradation due to GLP-1 weight-loss drugs, aging (sarcopenia), and cancer cachexia. They utilize lab-developed, highly evolved muscle tissues that simulate natural muscle, enabling the firm to swiftly and efficiently test and filter drug candidates. This cutting-edge platform diminishes the dependence on animal testing and reduces the cost of research. With the increasing demand for muscle-preservation therapies, ProFuse is broadening its reach from cultivated meat to biopharma, proposing an innovative strategy to tackle the escalating challenges associated with muscle health.
What Are the Main Segments in the Digital Therapeutics Sarcopenia Market?
The digital therapeutics sarcopenia market covered in this report is segmented
1) By Product: Software, Devices, Services
2) By Distribution Channel: Online Platforms, Pharmacies, Other Distribution Channels
3) By Application: Muscle Strengthening, Physical Activity Monitoring, Nutrition Management, Other Applications
4) By End User: Hospitals And Clinics, Homecare Settings, Rehabilitation Centers, Other End Users
Subsegments:
1) By Software: Mobile Applications, Web-Based Platforms, AI-Powered Monitoring Tools, Exercise And Rehabilitation Programs, Nutritional Guidance Software
2) By Devices: Wearable Fitness Trackers, Smart Scales, Connected Resistance Bands, Electromyography (EMG) Devices, Muscle Strength Assessment Tools
3) By Services: Remote Patient Monitoring Services, Virtual Physiotherapy Sessions, Teleconsultation Services, Personalized Coaching Services, Data Analytics And Reporting Services
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=27278&type=smp
Which Top Companies are Driving Growth in the Digital Therapeutics Sarcopenia Market?
Major companies operating in the digital therapeutics sarcopenia market are Noom Inc., Sword Health Inc., Biofourmis Inc., Hinge Health Inc., Omada Health Inc., Virta Health Corp., Evolv Rehabilitation Technologies Ltd., Click Therapeutics Inc., DarioHealth Corp., WellDoc Inc., Propeller Health, Lark Technologies Inc., mySugr GmbH, SilverCloud Health Limited (a part of Amwell), Kaia Health Software GmbH, Liva Healthcare A/S, Zibrio Inc., Gait Up SA, Noraxon Inc., Mira Rehab Limited, and Cometa Srl.
Which Regions Will Dominate the Digital Therapeutics Sarcopenia Market Through 2029?
North America was the largest region in the digital therapeutics sarcopenia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital therapeutics sarcopenia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=27278
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Comorbidities Fueling The Growth Of The Market Due To Increasing Aging Population And Obesity Risk: Strengthening the Growth Trajectory of the Digital Therapeutics Sarcopenia Market here
News-ID: 4171123 • Views: …
More Releases from The Business Research Company

Key Drivers Reshaping the Purvalanol A (CDK Inhibitor) Market: Increasing Preval …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Purvalanol A (CDK Inhibitor) Market Size Growth Forecast: What to Expect by 2025?
The market size for purvalanol A (CDK inhibitor) has witnessed a substantial expansion in the past few years. It is projected to escalate from $0.58 billion in 2024 to $0.64 billion in 2025, with a compound…

Growing Emphasis On Personalized Medicine Driving The Market Due To Advances In …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Polygenic Risk Score Services Market Size Growth Forecast: What to Expect by 2025?
The market size for polygenic risk score services has seen considerable growth in recent years. Anticipated to increase from $1.24 billion in 2024 to $1.45 billion in 2025, it projects a compound annual growth rate (CAGR)…

Future of the Global Pharmaceutical Unit-Dose Packaging Market: Trends, Innovati …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Pharmaceutical Unit-Dose Packaging Market Size Growth Forecast: What to Expect by 2025?
The market size of the pharmaceutical unit-dose packaging industry has experienced quick expansion in the recent past. The market, valued at $48.78 billion in 2024, is projected to rise to $54.50 billion in 2025, reflecting a compound…

Personal Care Product Testing Market Poised to Hit $10.37 Billion by 2029 with A …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Personal Care Product Testing Market Size Growth Forecast: What to Expect by 2025?
In the past few years, the market size for personal care product testing has seen robust growth. It's projected to increase from $7.28 billion in 2024 to $7.84 billion in 2025, with a compound annual growth…
More Releases for Digital
Introducing Digital Sales Pro, Inc: Revolutionizing Digital Sales in the Digital …
Digital Sales Pro, Inc. is a company that helps content creators and publishers make money from content and reach a larger audience with their craft.
In today's world, it can be tough for content creators and publishers to make money and connect with their audience.
At, Digital Sales Pro, Inc. we understand these challenges and have created a suite of solutions that help our clients build a strong online presence, monetize…
Digital Twin in Healthcare Market Analysis By Type - Product Digital Twins, Proc …
Introduction
The healthcare industry has seen significant growth and development over the years, with technology playing a critical role in transforming patient care. One such innovative technology that has emerged in recent years is the Global Digital Twin in Healthcare Market. This technology allows healthcare professionals to create a virtual replica of a patient's physical self, enabling them to monitor and analyze patient data in real-time. The Global Digital Twin in…
Digital Twin in Healthcare Market Analysis By Type - Product Digital Twins, Proc …
In 2021, the market for Digital Twin in Healthcare worldwide was worth $6.75 billion US dollars. AMR Group projects that the market will reach US$ 96.5 billion by 2031, growing at a CAGR of 40 percent between 2022 and 2031.
Industry Overview
Digital twins are virtual copies of physical objects or things that data scientist & IT professionals can use to compute simulations prior to developing and deploying the original devices. Digital…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
Digital Advertising on Mobil Market Analysis 2019 Top Growing Companies: Adverti …
Digital Advertising on Mobil Market
Digital Advertising on Mobile Market is a type of advertising that shows that mobile devices such as smart phones and tablets have wireless connectivity. For mobile devices with fewer lenses than computers or laptops, digital media formats are often the most suitable for small displays through outputs. Telephone advertising is the communication of products or services of mobile devices and consumers. Telephone announcements range from…
Digital Display Market Future Growth with Worldwide Players (Digital Virgo, Digi …
Digital Display Industry 2019 Global Market 2025 research report represents the historical overview of current Market situation, size, share, trends, growth, supply, outlook and manufacturers with detailed analysis. It also focuses on Digital Display volume and value at global level, regional level and company level. From a global perspective, this report represents overall Digital Display market size by analyzing historical data and future prospect.
Get Sample Copy of this Report -…